Annual Working Capital
$3.85 M
+$3.17 M+467.96%
December 31, 2023
Summary
- As of February 8, 2025, CYTH annual working capital is $3.85 million, with the most recent change of +$3.17 million (+467.96%) on December 31, 2023.
- During the last 3 years, CYTH annual working capital has fallen by -$6.53 million (-62.90%).
- CYTH annual working capital is now -75.33% below its all-time high of $15.61 million, reached on December 31, 2021.
Performance
CYTH Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
-$15.46 M
-$10.09 M-187.53%
September 30, 2024
Summary
- As of February 8, 2025, CYTH quarterly working capital is -$15.46 million, with the most recent change of -$10.09 million (-187.53%) on September 30, 2024.
- Over the past year, CYTH quarterly working capital has dropped by -$19.31 million (-501.63%).
- CYTH quarterly working capital is now -199.09% below its all-time high of $15.61 million, reached on December 31, 2021.
Performance
CYTH Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
CYTH Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +468.0% | -501.6% |
| 3 y3 years | -62.9% | -501.6% |
| 5 y5 years | +356.0% | -501.6% |
CYTH Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -75.3% | +468.0% | -199.1% | at low |
| 5 y | 5-year | -75.3% | +468.0% | -199.1% | at low |
| alltime | all time | -75.3% | +1245.2% | -199.1% | at low |
Cyclo Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$15.46 M(+187.5%) |
| Jun 2024 | - | -$5.38 M(<-9900.0%) |
| Mar 2024 | - | $33.70 K(-99.1%) |
| Dec 2023 | $3.85 M(+468.0%) | $3.85 M(-446.6%) |
| Sep 2023 | - | -$1.11 M(-28.2%) |
| Jun 2023 | - | -$1.55 M(+205.8%) |
| Mar 2023 | - | -$506.10 K(-174.7%) |
| Dec 2022 | $677.90 K(-95.7%) | $677.90 K(-87.8%) |
| Sep 2022 | - | $5.55 M(-42.7%) |
| Jun 2022 | - | $9.68 M(-25.4%) |
| Mar 2022 | - | $12.97 M(-16.9%) |
| Dec 2021 | $15.61 M(+50.4%) | $15.61 M(+106.1%) |
| Sep 2021 | - | $7.57 M(-31.7%) |
| Jun 2021 | - | $11.09 M(-22.6%) |
| Mar 2021 | - | $14.31 M(+37.9%) |
| Dec 2020 | $10.38 M(+1170.4%) | $10.38 M(-1864.9%) |
| Sep 2020 | - | -$588.00 K(-70.1%) |
| Jun 2020 | - | -$1.97 M(+6.2%) |
| Mar 2020 | - | -$1.85 M(-327.1%) |
| Dec 2019 | $816.90 K(-3.2%) | $816.90 K(-75.6%) |
| Sep 2019 | - | $3.35 M(-28.6%) |
| Jun 2019 | - | $4.70 M(-595.0%) |
| Mar 2019 | - | -$949.20 K(-212.4%) |
| Dec 2018 | $844.30 K(-11.4%) | $844.30 K(+1407.7%) |
| Sep 2018 | - | $56.00 K(-93.3%) |
| Jun 2018 | - | $831.70 K(+479.2%) |
| Mar 2018 | - | $143.60 K(-84.9%) |
| Dec 2017 | $952.80 K(-26.3%) | $952.80 K(+14.1%) |
| Sep 2017 | - | $835.10 K(-41.0%) |
| Jun 2017 | - | $1.42 M(-36.7%) |
| Mar 2017 | - | $2.24 M(+72.9%) |
| Dec 2016 | $1.29 M(-15.4%) | $1.29 M(+13.2%) |
| Sep 2016 | - | $1.14 M(-34.6%) |
| Jun 2016 | - | $1.75 M(+98.0%) |
| Mar 2016 | - | $882.20 K(-42.3%) |
| Dec 2015 | $1.53 M(-28.4%) | $1.53 M(-38.5%) |
| Sep 2015 | - | $2.48 M(+96.5%) |
| Jun 2015 | - | $1.26 M(-23.2%) |
| Mar 2015 | - | $1.65 M(-22.9%) |
| Dec 2014 | $2.13 M(+408.3%) | $2.13 M(-31.6%) |
| Sep 2014 | - | $3.12 M(+83.7%) |
| Jun 2014 | - | $1.70 M(+69.9%) |
| Mar 2014 | - | $999.50 K(+138.0%) |
| Dec 2013 | $419.90 K(-2976.0%) | $419.90 K(-17.4%) |
| Sep 2013 | - | $508.10 K(-11.1%) |
| Jun 2013 | - | $571.70 K(+344.6%) |
| Mar 2013 | - | $128.60 K(-980.8%) |
| Dec 2012 | -$14.60 K | -$14.60 K(-93.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2012 | - | -$240.40 K(-9.7%) |
| Jun 2012 | - | -$266.30 K(+33.4%) |
| Mar 2012 | - | -$199.60 K(-40.6%) |
| Dec 2011 | -$336.20 K(-227.5%) | -$336.20 K(+435.4%) |
| Sep 2011 | - | -$62.80 K(-127.8%) |
| Jun 2011 | - | $225.50 K(-54.1%) |
| Mar 2011 | - | $491.00 K(+86.3%) |
| Dec 2010 | $263.60 K(-50.9%) | $263.60 K(+19.4%) |
| Sep 2010 | - | $220.80 K(-22.5%) |
| Jun 2010 | - | $285.00 K(-35.9%) |
| Mar 2010 | - | $444.80 K(-17.2%) |
| Dec 2009 | $536.90 K(+20.8%) | $536.90 K(-0.3%) |
| Sep 2009 | - | $538.70 K(+18.8%) |
| Jun 2009 | - | $453.30 K(+5.7%) |
| Mar 2009 | - | $428.70 K(-3.5%) |
| Dec 2008 | $444.30 K(-11.8%) | $444.30 K(-14.1%) |
| Sep 2008 | - | $517.00 K(+14.7%) |
| Jun 2008 | - | $450.90 K(-3.3%) |
| Mar 2008 | - | $466.50 K(-7.4%) |
| Dec 2007 | $503.70 K(+90.9%) | $503.70 K(-3.0%) |
| Sep 2007 | - | $519.50 K(+25.4%) |
| Jun 2007 | - | $414.20 K(+35.4%) |
| Mar 2007 | - | $305.80 K(+15.9%) |
| Dec 2006 | $263.80 K(+9.6%) | $263.80 K(+28.1%) |
| Sep 2006 | - | $205.90 K(-11.4%) |
| Jun 2006 | - | $232.50 K(-5.0%) |
| Mar 2006 | - | $244.80 K(+1.7%) |
| Dec 2005 | $240.70 K(+1395.0%) | $240.70 K(-16.0%) |
| Sep 2005 | - | $286.70 K(+18.0%) |
| Jun 2005 | - | $243.00 K(+13.2%) |
| Mar 2005 | - | $214.70 K(+1233.5%) |
| Dec 2004 | $16.10 K(-91.7%) | $16.10 K(-2112.5%) |
| Sep 2004 | - | -$800.00(-97.4%) |
| Jun 2004 | - | -$30.30 K(-113.9%) |
| Mar 2004 | - | $217.60 K(+12.5%) |
| Dec 2003 | $193.50 K(+68.8%) | $193.50 K(+110.8%) |
| Sep 2003 | - | $91.80 K(+4.2%) |
| Jun 2003 | - | $88.10 K(-2.5%) |
| Mar 2003 | - | $90.40 K(-21.1%) |
| Dec 2002 | $114.60 K(-211.8%) | $114.60 K(-15.7%) |
| Sep 2002 | - | $135.90 K(+151.2%) |
| Jun 2002 | - | $54.10 K(+309.8%) |
| Mar 2002 | - | $13.20 K(-112.9%) |
| Dec 2001 | -$102.50 K(-20.4%) | -$102.50 K(-43.6%) |
| Sep 2001 | - | -$181.60 K(+14.9%) |
| Jun 2001 | - | -$158.00 K(-21.4%) |
| Mar 2001 | - | -$201.10 K(+56.3%) |
| Dec 2000 | -$128.70 K | -$128.70 K(+56.8%) |
| Sep 2000 | - | -$82.10 K |
FAQ
- What is Cyclo Therapeutics annual working capital?
- What is the all time high annual working capital for Cyclo Therapeutics?
- What is Cyclo Therapeutics annual working capital year-on-year change?
- What is Cyclo Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Cyclo Therapeutics?
- What is Cyclo Therapeutics quarterly working capital year-on-year change?
What is Cyclo Therapeutics annual working capital?
The current annual working capital of CYTH is $3.85 M
What is the all time high annual working capital for Cyclo Therapeutics?
Cyclo Therapeutics all-time high annual working capital is $15.61 M
What is Cyclo Therapeutics annual working capital year-on-year change?
Over the past year, CYTH annual working capital has changed by +$3.17 M (+467.96%)
What is Cyclo Therapeutics quarterly working capital?
The current quarterly working capital of CYTH is -$15.46 M
What is the all time high quarterly working capital for Cyclo Therapeutics?
Cyclo Therapeutics all-time high quarterly working capital is $15.61 M
What is Cyclo Therapeutics quarterly working capital year-on-year change?
Over the past year, CYTH quarterly working capital has changed by -$19.31 M (-501.63%)